Tactile Systems Technology (NASDAQ:TCMD) Upgraded by StockNews.com to “Strong-Buy” Rating

StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMD) from a buy rating to a strong-buy rating in a research note published on Wednesday.

A number of other equities research analysts also recently commented on the stock. Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. BTIG Research lowered Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th. Finally, B. Riley assumed coverage on Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price on the stock.

Tactile Systems Technology Stock Performance

Shares of NASDAQ TCMD opened at $17.57 on Wednesday. The company has a quick ratio of 3.80, a current ratio of 4.37 and a debt-to-equity ratio of 0.12. The firm’s 50-day moving average price is $17.08 and its 200-day moving average price is $14.54. Tactile Systems Technology has a 52-week low of $11.12 and a 52-week high of $21.10. The company has a market cap of $421.63 million, a PE ratio of 27.03 and a beta of 1.21.

Hedge Funds Weigh In On Tactile Systems Technology

Large investors have recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new stake in shares of Tactile Systems Technology in the third quarter worth $29,000. Gladius Capital Management LP purchased a new stake in Tactile Systems Technology in the 3rd quarter worth $44,000. Quarry LP purchased a new stake in Tactile Systems Technology in the 2nd quarter worth $46,000. SG Americas Securities LLC bought a new stake in Tactile Systems Technology during the third quarter valued at about $156,000. Finally, Magnetar Financial LLC purchased a new position in shares of Tactile Systems Technology in the second quarter valued at about $130,000. Hedge funds and other institutional investors own 83.43% of the company’s stock.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.